Gedea Biotech Ab
Clinical trials sponsored by Gedea Biotech Ab, explained in plain language.
-
New vaginal tablet shows promise in taming recurrent bacterial vaginosis
Disease control CompletedThis study tested the safety of using pHyph, a vaginal tablet that naturally restores acidity, for 12 days in 32 adult women with bacterial vaginosis (BV). BV is a common infection causing unpleasant discharge and odor, and often returns after antibiotic treatment. The goal was t…
Phase: NA • Sponsor: Gedea Biotech AB • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
New vaginal device shows promise for yeast infections in small trial
Disease control CompletedThis study tested a vaginal pessary (Gedea) in 26 women with yeast infections. Participants used the device daily for 6 days. Researchers checked if symptoms like itching and burning went away by day 7 to 14. The goal was to see if the device could safely treat the infection with…
Phase: NA • Sponsor: Gedea Biotech AB • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC